The optimal dosing regimen for antibiotics used in combination therapy against drug-resistant bacteria should be determined through careful consideration of these factors, along with ongoing monitoring and adjustment as needed. Pharmacokinetic and pharmacodynamic modeling and simulations can be useful tools for determining the optimal dosing regimen and evaluating its effectiveness. Clinical trials are also important for evaluating the safety and efficacy of different dosing regimens in humans.